After careful consideration, the HCV2021 Organising Committee has decided to make the upcoming 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2021) a fully virtual event, taking place from July 6-9, 2021.
We want to thank you for your continued support of our Symposium. We are fully committed to creating an excellent virtual learning experience and strive to ensure that high-quality scientific content will be able to reach our members and partners around the world, in a safe and accessible manner.
Like our previous Symposia, HCV2021 will offer basic and clinical investigators an international platform to discuss the remaining challenges in the HCV field and novel approaches to tackle them towards this aim. Keynote lecturers and high-quality abstract submitters will have the ability to showcase the latest research and advancements in the field of Hepatitis C Virus and Related Viruses. We have also added a session to discuss the virological similarities and interactions between SARS-CoV2 and HCV leading to the development of novel antivirals and therapeutics. Finally, we will have the pleasure to celebrate and pay tribute to our Nobel laureates Drs. Harvey Alter, Michael Houghton, and Charlie Rice.
The abstract submission is now open with a newly added COVID-19 and SARS-CoV-2 / HCV co-infection topic. There are plenty of oral presentation spots throughout the program, so submit your abstract today to have your research reviewed for oral and poster presentation spots. If you have any questions, please contact us at firstname.lastname@example.org.
Stay safe and healthy.
HCV2021 Meeting Co-Chairs